Category

VIDEO

Panel: Utilizing Data Collection and Analytics to Measure ROI and Training Effectiveness
LEARNING, VIDEO, LEARNING

Panel: Utilizing Data Collection and Analytics to Measure ROI and Training Effectiveness

How are we measuring the effectiveness of training initiatives?
Strategies for using data collection and analytics to identify trends in learning behaviors, track performance, and pinpoint areas where further investment is needed
Identifying areas that require investment for building robust data-collection policies, tools, and training
How can we create smarter training plans that are tailored specifically to our employees’ needs?
Assessing learning experiences quickly according to the changing industry trends or dynamic markets

Continue reading
Transitioning Towards a Skills-Based Organization
LEARNING, VIDEO, LEARNING

Transitioning Towards a Skills-Based Organization

Katie Lackey serves as Vice President of Global Learning and Talent Management at Honeywell, a multinational conglomerate known for its cutting-edge technology and solutions across various industries. In this role, Katie leads the development and execution of strategic initiatives to cultivate a high-performing, inclusive, and skilled workforce across Honeywell’s global operations. With a strong background in human resources and organizational development, she leverages her expertise to drive employee engagement, professional growth, and talent optimization. Katie is known for her strategic mindset and collaborative approach, fostering a culture of continuous learning and innovation. She is committed to advancing diversity, equity, and inclusion within Honeywell, ensuring the company’s talent strategy aligns with its business objectives. Prior to her current position, Katie held various leadership roles in talent management and organizational effectiveness.

Continue reading
Supporting Growth: The Vital Role of Leaders in Helping Employees Navigate Their Careers
LEARNING, VIDEO, LEARNING

Supporting Growth: The Vital Role of Leaders in Helping Employees Navigate Their Careers

How can leaders serve as role models by demonstrating a commitment to personal and professional growth?

What steps can leaders take to secure resources and advocate for employee development at an organizational level?

How can leaders identify and remove barriers to career advancement, such as systemic biases or limited opportunities?

What methods can managers use to collaborate with employees on stretch assignments that enhance their skills?

How can leaders cultivate a growth mindset and encourage resilience in employees’ career development journeys?

Continue reading
Leadership Transformation Through Being More BMW
LEARNING, VIDEO, LEARNING

Leadership Transformation Through Being More BMW

Focusing on effective programs, systems, and processes to engage and retain top talent that will deliver maximum employee retention

Making sure that you are purposeful when designing and building your company culture and aligning leadership on values

Understanding employee eagerness to stay with companies that deliver both upward and lateral development and long term professional growth

Exploring the benefits of developing robust talent review processes

Continue reading
Lead. Inspire. Transform: Advancing Excellence Through Coaching
LEARNING, VIDEO, LEARNING

Lead. Inspire. Transform: Advancing Excellence Through Coaching

International Coaching Federation Global Enterprise, Inc.
Step into the world of coaching with the International Coaching Federation (ICF), the global force driving the coaching profession forward. With over 60,000 members from over 150 countries and territories, our mission is clear: to elevate coaching’s significance in building a thriving society, making it the core of empowerment for today’s and tomorrow’s generations.
Driven by forward-thinking, excellence, and humanity, our diverse community of members along with our six unique family organizations, unite under the ICF umbrella to empower everyone to become their best selves.
Together, we inspire, transform, and thrive: coachingfederation.org

Continue reading
How AI Reshapes Leadership Development and the Workplace
LEARNING, VIDEO, LEARNING

How AI Reshapes Leadership Development and the Workplace

Abilitie
Since 2015, Abilitie has been at the forefront of business education and leadership development, crafting lively programs that blend human connection and technology to deliver transformational experiences for organizations, teams, and individuals. Our dynamic offerings, including the flagship 12-Week MBA program, focus on core business skills such as financial acumen, leadership, strategy, and decision-making.

Abilitie’s curriculum helps leaders develop the timeless and universal capabilities required to manage numbers and lead people. We provide more than frameworks and tools. Our expert faculty guides leaders through collaborative and competitive simulations and case studies. We’ve had the privilege of working with thousands of leaders at hundreds of companies across dozens of industries. In our experience, the true challenge of leadership lies in leveraging relationships to drive results and driving results to build relationships at one and the same time.

Trusted by over 100 Fortune 500 clients, including Dell, GE, Coca-Cola, and Southwest Airlines, we invite organizations to discover how Abilitie can enhance employees’ abilities to navigate real-world management and strategy scenarios. Our commitment to leadership excellence has earned us recognition as a leading solutions provider; in 2024 Abilitie was named to Training Industry’s Top 20 Leadership Training Companies list and ranked #842 on the Inc. 5000.

Propel your leaders to their potential today with Abilitie.

Continue reading
The Speaker Roundtable from BMWS24 — A Conversation About Biopharmaceutical Manufacturing Issues and Ideas
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST, ROUNDTABLES

The Speaker Roundtable from BMWS24 — A Conversation About Biopharmaceutical Manufacturing Issues and Ideas

For this special episode of Executive Platforms’ bluEPrint Podcast series we had some of the most senior speakers and delegates from the 2024 edition of the long-running Biomanufacturing World Summit series sit down and speak to the challenges and opportunities submitted by attendees of the event as they filled out their delegate profiles, weighted by popularity.

With topics ranging from leadership and culture, to talent attraction, development and retention, to supply chain issues, to commercializing CGTs and other ATMPs, change and disruption throughout the business landscape, and how to serve patients better now and in the future, this wide-ranging conversation sees five senior executives from five very different companies speaking to the issues, ideas, innovations, and inspirations that matter to all of them as guided by a moderator who knows the industry inside and out. It is a fantastic deep dive into what is most relevant to biopharma technical operations leaders today. Give it a listen!

Continue reading
Navigating the Modalities Landscape: Adapting Manufacturing Strategies for Future Therapeutic Advances
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Navigating the Modalities Landscape: Adapting Manufacturing Strategies for Future Therapeutic Advances

Sanat Chattopadhyay is responsible for the company’s (approx. $64 billion revenue) worldwide manufacturing and supply operations across a global network of sites for pharmaceuticals, vaccines, biologics and animal health products. Merck is known as MSD outside of the U.S. and Canada.

Sanat joined Merck in 2009 as Senior Vice President of Global Vaccines & Sterile Manufacturing Operations, spearheading the transformation of manufacturing and supply chain to grow and globalize its Vaccine business. Under Sanat’s leadership, Merck is currently executing a significant expansion of its biologics and vaccines manufacturing capacity with planned capital investments of more than $20 billion from 2020 through the end of 2024, to reach more patients around the globe.

Before joining Merck, he served as Senior Vice President, Technical Operations & Product Supply, for Wyeth Pharmaceuticals. Previously, he worked at Aventis and its predecessor companies as Senior Vice President, Industrial Operations, having served in many positions with increasing responsibilities for global supply chain, technology and manufacturing sites across North America, Europe and Asia Pacific. Sanat started his career with Hoechst Pharmaceuticals in 1983 and worked in many senior leadership assignments.

Sanat is a graduate in Chemical Engineering and holds a post-graduate degree in Industrial Engineering from India.

Outside of Merck, Sanat is a member of the Board of Directors of Ashland Inc.

Continue reading
FUTURE READY: Addressing Current Challenges in Biomanufacturing with Reliability, Efficiency, Agility, Data & (High) Yields
LIFE SCIENCES, VIDEO, LIFE SCIENCES

FUTURE READY: Addressing Current Challenges in Biomanufacturing with Reliability, Efficiency, Agility, Data & (High) Yields

Jerry Murry, is Senior Vice President of Process Development at Amgen. Jerry started his career at Amgen in 2006 as Executive Director, Process Development within the Translational Sciences organization in R&D, and was promoted to Vice President, Process Development in 2010. In 2012, Jerry joined the Amgen Full Potential Transformation team as lead of the initiative “Transforming Process Development at Amgen”(AFP3).

In 2014, as part of the integration and reorganization of a new single, global process development team, Jerry was named the head of CMC Lifecycle management with responsibility for Operations Commercialization activities including regulatory filings and launches.

In 2016, Jerry became head of Drug Product Technologies with responsibility for all formulation and product and process development.
In 2018, Jerry was promoted to Senior Vice President Process Development at Amgen with responsibilities for all global Process Development activities.

Prior to joining Amgen, Jerry spent 8 years at Pfizer Central Research and 6 years at Merck Research Laboratories in Process Development.

Jerry earned BA/BS in Biology and Chemistry at Texas Lutheran University, a PhD in Chemistry from University of Utah and was an NIGMS NIH Fellow at Harvard University.

Continue reading
Innovative CMC Contributions: Advancing the Future of Patient Care, Society & Roche
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Innovative CMC Contributions: Advancing the Future of Patient Care, Society & Roche

Tongtong joined Genentech in 2018 as the head of Pharmaceutical Technical Development for US Biologics, and was named global head of Pharma Technical Development in April 2021. Prior to her role at Genentech, Tongtong held several scientific, managerial and strategic roles at Eli Lilly, with increasing responsibilities in the Bioproduct Research and Development organisation. Tongtong also worked at Corixa Corporation, a biotech company, where she gained valuable experiences both as a discovery scientist and as a CMC leader in support of therapeutic antibody and cancer vaccine platforms.

Tongtong received her B. Sc. in Molecular Biology from University of Science and Technology of China, a doctorate in Biology from Syracuse University, and completed her postdoctoral training in cell biology and yeast genetics at Cornell University.

Continue reading
Authentic Leadership
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Authentic Leadership

As Chief Global Supply Officer, Executive Vice President, Mike McDermott leads Pfizer’s internal and external manufacturing and supply chain activities.

Mike and the Pfizer Global Supply (PGS) team work to ensure uninterrupted supply for Pfizer’s entire product portfolio. This includes hundreds of medicines and vaccines provided to more than 185 countries worldwide. The PGS network, which includes more than 30 global manufacturing sites and approximately 31,000 colleagues, also works with more than 300 contract manufacturers to produce 50 billion doses of medicines and vaccines each year.

Mike has more than 30 years of industry experience, having joined Pfizer in 1989, by way of Wyeth, after starting as a Project Engineer in Pearl River, New York. He has held many roles, including Plant Manager and Operational Vice President of multiple divisions, including Consumer Healthcare, Biotechnology and Supply Chain, as well as roles in Finance and Marketing.

He was named President of PGS in 2018 and assumed his current role in January 2022.

A passionate advocate for Diversity, Equity and Inclusion, Mike has enacted impactful changes to increase diversity within PGS and was recently named Executive Sponsor of Pfizer’s Women’s Resource Group, the company’s largest Colleague Resource Group.

In addition to ambitious goals related to product supply at launch and manufacturing cycle times, Mike and PGS support Pfizer’s Net Zero strategy, which includes delivering Greenhouse Gas reductions.

Mike, his wife Katie and their five daughters – of whom he is incredibly proud – are committed to community engagement and social action. An active volunteer himself, Mike was a Board Member for People to People, a non-profit organization which helps under-served communities, for 10 years.

Mike holds Bachelor of Science and Master of Science degrees in Industrial Engineering from the New Jersey Institute of Technology (NJIT), where he has been an adjunct professor. He was named an NJIT Distinguished Alumnus and is the recipient of the 2023 Newark College of Engineering Outstanding Alumnus Award.

Mike serves on the Executive Committee of the National Association of Manufacturers and is a member of the Pharmaceutical Manufacturers Forum.

Continue reading
Empowering A Culture of Operational Excellence For Sustainable Growth
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Empowering A Culture of Operational Excellence For Sustainable Growth

Tina Self is a dynamic leader with over 20 years of experience in the biotech and pharmaceutical industries, specializing in quality and manufacturing. Currently, she serves as the Senior Vice President of Global Biologics Manufacturing and Berkeley Site Head at Bayer. Tina has been with Bayer for over eight years, where she has held several key leadership roles, including Vice President of Manufacturing Operations and Vice President of Quality. She is recognized for her strategic oversight of manufacturing processes, commitment to quality assurance, and her ability to drive continuous improvement. Tina holds an MS in Biotechnology from The Johns Hopkins University and an MBA in International Business from Florida Atlantic University.

Continue reading
Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

Assessing Changes in the CMC Ecosystem: Are We Overbuilding Capacity Again?
Uniting for Success: Strategies to Prevent Fragmentation and Foster Collaboration in Biomanufacturing
Pioneering New Ventures: Reasons to Establish a New Company Today and Anticipating Future Growth in the Business Ecosystem
Evaluating Production Platforms for Emerging Modalities: Which Platforms Will Best Serve the Future of Medicine?
Navigating the Future of Existing Platforms: Efficiently Addressing Market Needs for Established Therapies such as mAbs, ADCs, and mRNA-based Treatments

Continue reading
Welcome Day Panel: The Five Biggest Things Facing Our Shared Biomanufacturing Future
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Welcome Day Panel: The Five Biggest Things Facing Our Shared Biomanufacturing Future

Discussing the most important new technologies in biomanufacturing today, with a special emphasis on what we want to do as our industry matures
Debating how talent and workforce development in our industry is changing, and what we should do about it
Listing the current factors affecting speed of development and efficient manufacturing. How do we continue to improve in a changing business landscape with special reference to IRA and the BIOSECURE Acts?
Understanding the current Regulatory environment with an eye for how things are going to evolve into the future
How can we improve the access of biologic medicines?

Continue reading
Accelerating the Pace of Progress for Innovative Biologic Products
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Accelerating the Pace of Progress for Innovative Biologic Products

Peter Marks received his graduate degree in cell and molecular biology and his medical degree at New York University and completed Internal Medicine residency and Hematology/Medical Oncology training at Brigham and Women’s Hospital in Boston. He has worked in academic settings teaching and caring for patients and in industry on drug development. He joined the FDA in 2012 as Deputy Center Director for CBER and became Center Director in January 2016.

Continue reading
Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development

Science outpacing Industrialization of Technology: Reviewing next generation cell and gene therapy platforms/technologies, gene editing technologies to unlock new possibilities.
Manufacturing to Scale: Scaling up to meet demand, comparability challenges, production capacity, AI tools and AAV production will drive speed to market/approval
Regulatory Evolution: evolving regulatory frameworks and innovative products necessitate industry and local and global regulatory collaboration to define efficient pathways to approval
Economic/Global Expansion: expanding access to ATMP’s in new regions, reducing cost of goods via production efficiency, expanding global infrastructure to facilitate access to new patients

Continue reading